Peptide Medicine
GHK-Cu (Copper Peptide): Uses, Benefits, and Safety
Medically reviewed by HealthRX.com Medical Team · Last reviewed
What is GHK-Cu?
GHK-Cu is a small copper-carrying peptide that occurs naturally in human blood, saliva and urine. It pairs the tripeptide GHK (glycine-histidine-lysine) with a copper ion. It was first identified in 1973, and the body's levels decline steadily with age.
GHK was first isolated from human plasma in 1973 by Loren Pickart, who observed that it helped older liver tissue behave more like younger tissue. The peptide binds copper with high affinity, forming the complex written as GHK-Cu. [1]
Levels fall with age. Plasma GHK is reported at roughly 200 nanograms per milliliter around age 20 and closer to 80 nanograms per milliliter by age 60, a decline that researchers have linked to slower tissue repair. These figures come from the work of Pickart and colleagues and should be read as research observations rather than clinical targets. [1][2]
How does GHK-Cu work?
GHK-Cu carries copper into tissue and acts as a signaling molecule. Laboratory studies link it to collagen and elastin production, antioxidant activity, and reduced inflammatory signaling. A 2015 analysis reported that GHK can influence the expression of a large number of human genes involved in tissue repair.
Copper is required for several enzymes involved in building and remodeling skin. By delivering copper and modulating gene activity, GHK-Cu is studied as a signal that shifts tissue toward repair. A 2015 review by Pickart and colleagues reported that the peptide can change the expression of thousands of human genes, many tied to wound healing and tissue remodeling. [3]
In laboratory and animal models, GHK-Cu has been associated with increased collagen and elastin synthesis, antioxidant effects, and anti-inflammatory activity. These mechanisms are well documented in cell and tissue studies; how fully they translate to injected use in humans is still not established. [1][3]
What are the benefits of GHK-Cu, and what does the research show?
The strongest evidence is for skin. Topical GHK-Cu has been studied for firmness, wrinkles and wound healing, with supportive laboratory and cosmetic data. Evidence for hair growth is early, and controlled human trials of injectable GHK-Cu are limited, so systemic claims should be read with caution.
- Skin aging: topical copper-peptide formulations have shown improvements in skin firmness and appearance in cosmetic studies. [3]
- Wound healing: preclinical studies link GHK-Cu to faster tissue repair and collagen formation. [1][3]
- Hair: laboratory and early research suggest a role in hair-follicle support, though human evidence is limited. [3]
- Antioxidant and anti-inflammatory effects: documented in cell and tissue models. [1]
- Honest framing: most human evidence is topical or cosmetic. Injectable and systemic use is studied far less, and large controlled human trials are lacking.
How is GHK-Cu used and dosed?
Topical creams and serums are the best-studied form and are used daily on the skin. Injectable GHK-Cu is provider-directed and far less studied in humans. There is no single established injectable dose, and any injectable use should be supervised by a licensed clinician.
| Form | Typical use | Notes |
|---|---|---|
| Topical cream or serum | Applied daily to the skin | Best-studied route for skin and cosmetic use |
| Injectable (compounded) | Provider-directed | Limited human evidence; requires a prescription and clinical oversight |
Is GHK-Cu safe, and what are the side effects?
Topical GHK-Cu is generally well tolerated, with mild skin irritation as the most common complaint. Injectable use is less studied and carries the usual injection risks. People who are pregnant or breastfeeding, or who have a copper-metabolism disorder, should avoid it unless a clinician advises otherwise.
- Topical: occasional redness, itching or irritation at the application site.
- Injectable: injection-site reactions and the general risks of injection; long-term human safety data is limited.
- Avoid in copper-metabolism disorders such as Wilson disease unless directed by a clinician.
- Avoid in pregnancy or breastfeeding without medical advice, as safety has not been established.
Is GHK-Cu legal and FDA approved?
GHK-Cu is not an FDA-approved drug. It appears in many topical cosmetic products, and injectable forms are available only through compounding pharmacies on a valid prescription. It is not approved to diagnose, treat or cure any condition, and quality varies widely between sources.
Because injectable GHK-Cu is not an approved medication, it should only be obtained through a licensed provider and a reputable compounding pharmacy. Product purity, sterility and labeling are real concerns with peptides sold outside of that route. [1]
How does GHK-Cu compare with other peptides?
| GHK-Cu | BPC-157 | Sermorelin | |
|---|---|---|---|
| Primary focus | Skin, hair, healing | Tissue and tendon recovery | Growth-hormone support |
| Best evidence | Topical and cosmetic | Preclinical | Endocrine |
| Common route | Topical or injectable | Injectable | Injectable |
| FDA approved | No | No | No |
Frequently asked questions
Is GHK-Cu FDA approved?
No. GHK-Cu is not an FDA-approved drug. It is used in topical cosmetics, and injectable forms are available only through compounding pharmacies on a valid prescription.
Does GHK-Cu regrow hair?
Laboratory and early studies suggest GHK-Cu may support hair follicles, but human evidence is limited and it is not an approved hair-loss treatment.
Is topical or injectable GHK-Cu better?
Topical use is the best-studied route, especially for skin. Injectable GHK-Cu has limited human data and should only be used under medical supervision.
Does GHK-Cu boost collagen?
In laboratory and topical studies, GHK-Cu has been linked to increased collagen and elastin production. How strongly this applies to injected use in humans is not established.
Is GHK-Cu safe?
Topical GHK-Cu is generally well tolerated, with mild irritation as the main side effect. Injectable use is less studied. Avoid it in pregnancy, breastfeeding or copper disorders unless a clinician advises otherwise.
Citations
- Pickart L, Margolina A. Regenerative and Protective Actions of the GHK-Cu Peptide in the Light of the New Gene Data. Int J Mol Sci. 2018;19(7):1987.
- Pickart L. The human tri-peptide GHK and tissue remodeling. J Biomater Sci Polym Ed. 2008;19(8):969-988.
- Pickart L, Vasquez-Soltero JM, Margolina A. GHK Peptide as a Natural Modulator of Multiple Cellular Pathways in Skin Regeneration. Biomed Res Int. 2015;2015:648108.
This guide is educational and is not a substitute for individualized medical advice. GHK-Cu is prescription-only and requires evaluation by a licensed provider.